Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions. ASSET PURCHASE...Asset Purchase Agreement • March 1st, 2023 • IVERIC Bio, Inc. • Pharmaceutical preparations • New York
This ASSET PURCHASE AGREEMENT (together with all Schedules, this “Agreement”), effective as of December 23, 2022 (the “Effective Date”), is by and between IVERIC bio Gene Therapy LLC, a Delaware limited liability company with a place of business at 8 Sylvan Way, Parsippany, NJ 07054 (“Iveric”) and Opus Genetics Inc. a Delaware corporation with a place of business at 8 Davis Drive, Suite 220, Durham, NC 27709 (“Opus”).
OPUS GENETICS INC. STOCK ISSUANCE AGREEMENTStock Issuance Agreement • March 1st, 2023 • IVERIC Bio, Inc. • Pharmaceutical preparations • Delaware
This STOCK ISSUANCE AGREEMENT (this “Agreement”) is made this 23rd day of December, 2022, between Opus Genetics Inc., a Delaware corporation (the “Company”), and IVERIC bio Gene Therapy LLC, a Delaware limited liability company (“Iveric”).
